Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

An X-ray for Your Genes

October 8, 2010 6:45 am | News | Comments

Not every patient reacts to a medicine in the same way. The personal genetic characteristics of individuals and populations can explain why a specific prescription successfully treats one patient and not another.

TOPICS:

The Business of Recombinant Protein Production

October 7, 2010 11:05 am | by Joel White, Business Manager, Biotechnology; Ajinomoto AminoScience, Raleigh, North Carolina | Articles | Comments

The path to a functionally active recombinant pharmaceutical can be plagued with technical pitfalls and failures. Strategies can optimize use of time and resources.

TOPICS:

DNA Sequencing Kits

October 7, 2010 8:33 am | Product Releases | Comments

Bioo Scientific has expanded its line of kits for next generation sequencing sample preparation with the introduction of the AIR Genomic and AIR Paired-End DNA Sequencing Kits, designed for use with the llumina GAII and HiSeq 2000 sequencers.

TOPICS:
Advertisement

Mass Spectrometer

October 7, 2010 8:30 am | Product Releases | Comments

Thermo Fisher Scientific Inc. has announced the Thermo Scientific Prima PRO, a next-generation process massspectrometer for online gas analysis in biotechnology applications.

TOPICS:

Ricera Adds to Drug Safety Division

October 7, 2010 8:14 am | News | Comments

Ricerca Biosciences, a preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, has announced the addition of Eric J. Lubert, Ph.D., as a scientist in its drug safety division.

TOPICS:

GSK Announces Singapore Collaborations

October 7, 2010 8:11 am | News | Comments

GlaxoSmithKline R&D announced the start of four new academic collaborations with Singapore-based scientists and GSK’s global drug discovery network as the first step in a longer term plan to seek alliances with scientific experts in the country.

TOPICS:

Insoluble Nanodrugs Can Still Be Absorbed

October 7, 2010 8:08 am | News | Comments

Researchers in India have demonstrated that producing nanoscopic crystals of a pharmaceutical product can allow the medication to be absorbed by the gut even if the drug is not soluble in water.

TOPICS:

Zebrafish Tumors Similar to Humans

October 7, 2010 8:00 am | News | Comments

While human cells have 23 pairs of chromosomes, tumor cells usually have extra copies of some chromosomes. This trait, known as aneuploidy, appears to give tumor cells a survival edge.

TOPICS:
Advertisement

FDA Admits Need to Modernize

October 7, 2010 7:55 am | by Matthew Perrone | News | Comments

The Food and Drug Administration must update its scientific tools for reviewing prescription drugs, medical devices and tracking food safety, according to a research plan laid out by agency leadership.

TOPICS:

Prescription Drug Sales May Increase 7%

October 7, 2010 7:53 am | by Linda A. Johnson | News | Comments

Revenue from global prescription drug sales should increase 5 percent to 7 percent next year, reaching at least $880 billion, fueled by new drugs and rising sales in developing countries, according to drug data firm IMS Health.

TOPICS:

Rituximab Shows Benefits in Untreated CLL

October 7, 2010 7:46 am | News | Comments

The monoclonal antibody rituximab given in addition to a standard chemotherapy regimen of fludarabine plus cyclophosphamide significantly prolongs the lives of patients with chronic lymphocytic leukaemia compared with standard chemotherapy alone.

TOPICS:

Sanofi Publishes Jevtana Data

October 7, 2010 7:41 am | News | Comments

The data demonstrated that Jevtana with prednisone reduced the risk of death by 30% in men with metastatic castration-resistant prostate cancer whose disease progressed following treatment with a docetaxel-containing treatment regimen.

TOPICS:

Amgen Announces Results of Phase 3 Studies

October 7, 2010 7:36 am | News | Comments

Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer, respectively.

TOPICS:

ISTA Announces Positive Results of Allergy Study

October 7, 2010 7:29 am | News | Comments

ISTA Pharmaceuticals, Inc. announced positive preliminary results from a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies.

TOPICS:

Immunocore Melanoma Drug Receives Trial OK

October 7, 2010 7:24 am | News | Comments

Researchers at Immunocore Limited announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrollment for clinical trials in the UK and USA.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading